CAPR News

Capricor Therapeutics Announces Late-Breaking Presentation at 2026 MDA Clinical and Scientific Conference

Capriotti's Opens Second Oahu Location in Kapolei on February 10

Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Atkore Inc. (ATKR), Axsome Therapeutics, Inc. (AXSM), Capricor Therapeutics, Inc. (CAPR), and CTO Realty Growth, Inc. (CTO)

Capriotti's Serves Up High-Protein Subs Packed with Bold Flavor

RightBRIDGE Launches RightBRIDGE Annuity Book Management, a Revolutionary System for Annuity Life Cycle Management

Capricor Therapeutics Provides Regulatory Update on Deramiocel BLA Following FDA Review of HOPE-3 Topline Data

Exosome Research Market Projected to Reach US$ 2,491.42 Million by 2035, Supported by Expanding Therapeutic Development Pipelines | Astute Analytica

Capriotti's Sandwich Shop Opens New Location in Phoenix on January 7

Capricor Therapeutics and Parent Project Muscular Dystrophy to Host Webinar Highlighting Positive Phase 3 HOPE-3 Topline Results in Duchenne Muscular Dystrophy

Capricor Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock